PolyPid: Roth Capital Maintains Buy Rating with Lower PT of $9

Thursday, Nov 13, 2025 11:46 am ET1min read
PYPD--

PolyPid: Roth Capital Maintains Buy Rating with Lower PT of $9

PolyPid: Roth Capital Maintains Buy Rating with Lower PT of $9

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet